How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

613 results for

Pediatric Auditory Screening

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Influence of the WIC Program on Loss to Follow-up for Newborn Hearing Screening. (PubMed)

of WIC-eligible infants who referred on newborn hearing screens at target hospitals. Hearing rescreens were performed by using screening auditory brainstem response testing by trained research assistants, coordinated with the infant's WIC appointment. Loss to follow-up rates and age at follow-up were compared with non-WIC infants tracked via the Ohio Department of Health during the same time periods at the same hospitals and at nonintervention hospitals.During a 2-year period, there were 1493 hearing (...) of mothers reported barriers to follow-up.Collaborating with WIC to provide targeted follow-up for newborn hearing screening improved loss to follow-up rates, decreased the age at hearing confirmation by 1 month, and addressed reported care barriers.Copyright © 2016 by the American Academy of Pediatrics.

Full Text available with Trip Pro

2016 Pediatrics

42. Newborn Hearing Screening

Newborn Hearing Screening Newborn Hearing Screening Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Newborn Hearing Screening Newborn (...) Hearing Screening Aka: Newborn Hearing Screening , Hearing Testing in Newborns , Infant Hearing Testing , Auditory Brainstem-Evoked Response , Auditory Brainstem Response , Otoacoustic Emission , Transient Evoked Otoacoustic Emission , Auditory Brainstem Electric Response Audiometry II. Definition Newborn Hearing Screening III. Types: Screening Automated Auditory Brainstem Response (ABR) Tests auditory path from ear canal to low Headphones on newborn's ears emit soft clicks Forehead,neck electrodes

2018 FP Notebook

43. Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS)

: Intervention Active tDCS Not Applicable Detailed Description: Background: Early onset schizophrenia (EOS) involves positives symptoms such as psychotic behaviors, as well as negative symptoms such as disruptions to normal emotions and behaviors. Antipsychotics are the primary method of treatment in pediatric populations, but can produce unpleasant or dangerous side effects. Medication response is highly variable. Recent evidence demonstrates transcranial Direct Current Stimulation (tDCS) relieving auditory (...) Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS) Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2015 Clinical Trials

44. Speech perception and cortical auditory evoked potentials in cochlear implant users with auditory neuropathy spectrum disorders. (PubMed)

for Audiological Research at the University of São Paulo. The sample included 14 pediatric (4-11 years of age) cochlear implant users with ANSD, of both sexes, with profound prelingual hearing loss. Patients with hypoplasia or agenesis of the auditory nerve were excluded from the study. LLAEPs produced in response to speech stimuli were recorded using a Smart EP USB Jr. system. The subjects' speech perception was evaluated using tests 5 and 6 of the Glendonald Auditory Screening Procedure (GASP).The P(1 (...) Speech perception and cortical auditory evoked potentials in cochlear implant users with auditory neuropathy spectrum disorders. To characterize the P(1) component of long latency auditory evoked potentials (LLAEPs) in cochlear implant users with auditory neuropathy spectrum disorder (ANSD) and determine firstly whether they correlate with speech perception performance and secondly whether they correlate with other variables related to cochlear implant use.This study was conducted at the Center

2012 International Journal of Pediatric Otorhinolaryngology

45. The Effect of Amblyopia on Visual-Auditory Speech Perception: Why Mothers May Say "Look At Me When I'm Talking To You" (PubMed)

The Effect of Amblyopia on Visual-Auditory Speech Perception: Why Mothers May Say "Look At Me When I'm Talking To You" Children with a history of amblyopia, even if resolved, exhibit impaired visual-auditory integration and perceive speech differently.To determine whether a history of amblyopia is associated with abnormal visual-auditory speech integration.Retrospective observational study at an academic pediatric ophthalmologic clinic with an average of 4 years of follow-up. Participants were (...) at least 3 years of age and without any history of neurologic or hearing disorders. Of 39 children originally in our study, 6 refused to participate. The remaining 33 participants completed the study. Twenty-four participants (mean [SD] age, 7.0 [1.5] years) had a history of amblyopia in 1 eye, with a visual acuity of at least 20/20 in the nonamblyopic eye. Nine controls (mean [SD] age, 8.0 [3.4] years) were recruited from referrals for visually insignificant etiologies or through preschool-screening

Full Text available with Trip Pro

2014 JAMA ophthalmology

46. Auditory Neuropathy

of newborn hearing screening tests, the delay in diagnosis of AN/AD should be minimized, which will expedite intervention. Previous References Berlin CI, Hood L, Rose K. On renaming auditory neuropathy as auditory dys-synchrony. Auditory Today . 2002. 13:15-17. Nikolopoulos TP. Auditory dyssynchrony or auditory neuropathy: understanding the pathophysiology and exploring methods of treatment. Int J Pediatr Otorhinolaryngol . 2014 Feb. 78(2):171-3. . Kitao K, Mutai H, Namba K, et al. Deterioration (...) that have been associated with AN/AD. Although a complicated perinatal history is common among most patients with AN/AD, one third of patients have no predisposing factors that led to the development of AN/AD. A study by Kitao et al suggested that adults with auditory neuropathy/auditory dyssynchrony (AN/AD) have a higher rate of decrease in distortion product otoacoustic emissions (DPOAEs) than do pediatric patients with the disease (72% of ears vs 45% of ears, respectively), but a lower rate of DPOAE

2014 eMedicine Surgery

47. Auditory Brainstem Response Audiometry

that in BPI patients, as well as (somewhat less strongly) those with schizophrenia, the portion of the ABR curve containing waves VI and VII did not correlate well will that belonging to the controls. According to the investigators, the study’s results indicate that BPI may be associated with thalamocortical circuitry abnormalities. [ ] Previous Next: Newborn Hearing Screening Auditory brainstem response (ABR) technology is used in testing newborns. Approximately 1 of every 1000 children is born deaf (...) screening programs. These programs are possible because of the combination of technological advances in ABR and otoacoustic emissions (OAE) testing methods and equipment availability, which enables accurate and cost-effective evaluation of hearing in newborns. Several clinical trials have shown automated auditory brainstem response (AABR) testing (eg, Algo-1 Plus) as an effective screening tool in the evaluation of hearing in newborns, with a sensitivity of 100% and specificity of 96-98%. When used

2014 eMedicine Surgery

48. An overview of current management of auditory processing disorder (APD)

(modified from the Interim Position Statement on APD, BSA 2007): ? Detailed audiometry (including puretone audiometry, word recognition testing, OAEs +/- suppression, tympanometry, acoustic reflexes and/or ABR). These are necessary to differentiate between APD and other disorders such as Auditory Neuropathy Spectrum Disorder (ANSD) ? Auditory processing tests (which should include at least 1 non-speech test procedure) ? A screening language and cognitive assessment (including tests for auditory memory (...) An overview of current management of auditory processing disorder (APD) Practice Guidance An overview of current management of auditory processing disorder (APD) Date of this version: 1 st August 2011 Minor corrections: 17 th October 2011 Date for review: August 2013 Practice Guidance British Society of Audiology Management of APD 2011 © BSA 2011 2 General foreword This document presents Practice Guidance by the British Society of Audiology (BSA). This Practice Guidance represents, to the best

2010 British Society of Audiology

49. Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

auditory or visual hallucinations or presence of delusional thinking, bipolar disorder, substance-induced psychotic disorder, psychosis due to general medical condition. Severely depressed patients with the Children's Depression Rating Scale (CDRS) ≥ 60 or judged clinically to be at risk of suicide. Current diagnosis of an eating disorder. Current or past history of PTSD or significant trauma. Current or past diagnosis of substance abuse/dependence. Current or past diagnosis of pediatric autoimmune (...) Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2015 Clinical Trials

50. A diagnostic paradigm including cytomegalovirus testing for idiopathic pediatric sensorineural hearing loss. (PubMed)

A diagnostic paradigm including cytomegalovirus testing for idiopathic pediatric sensorineural hearing loss. To determine the feasibility and cost effectiveness of incorporating cytomegalovirus (CMV) testing to determine the etiology of pediatric hearing loss.Retrospective study of children presenting with sensorineural hearing loss (SNHL) at one institution from 2008 to 2013.Children aged 3 years or younger who presented to the senior author (A.P.) between May 2008 and September 2013 (...) with confirmed SNHL were evaluated. These children underwent a sequential diagnostic paradigm that incorporated CMV testing if no obvious etiology could be determined from the history or physical examination.One hundred eleven children with SNHL were evaluated between 2008 and 2013. Eighty-three children underwent CMV testing, imaging, and a genetic evaluation. Those with confirmed or probable CMV-induced SNHL made up 30% of all children tested (n = 25), the largest group identified. CMV screening had

2014 Laryngoscope

51. Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

immediately prior to Screening. The patient must have sufficient auditory capacity, with a hearing aid(s), if needed, in the Investigator's judgment to complete the required protocol testing and must be compliant with wearing the hearing aid(s), if needed, on scheduled testing days. The patient's parent(s) or legally authorized guardian(s) must have voluntarily signed an Institutional Review Board/Independent Ethics Committee approved informed consent form after all relevant aspects of the study have been (...) at Screening of Hunter syndrome-related cognitive impairment The patient has received and tolerated a minimum of 4 months of therapy with Elaprase during the period immediately prior to Screening. The patient must have sufficient auditory capacity, with a hearing aid(s), if needed, in the Investigator's judgment to complete the required protocol testing and must be compliant with wearing the hearing aid(s), if needed, on scheduled testing days. The patient's parent(s) or legally authorized guardian(s) must

2014 Clinical Trials

52. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review. (PubMed)

search was performed from 1970 to 2014. Randomized controlled trials, case-control studies, cohort studies, and case series including pediatric subjects with baseline auditory evaluations were included.Twelve studies (1979-2014) were reviewed. The study population included 762 children (5 months-20 years). Hearing screening measures included pure-tone audiometry (PTA) at standard ± high frequency threshold (HFPTA) (12/12), distortion product otoacoustic emissions (DPOAE) (4/12), transient-evoked (...) otoacoustic emissions (1/12), and automated auditory brainstem response (1/12). The overall prevalence of SNHL ranged from 0% to 29%. However, on subset analysis of children with greater than 10 courses of intravenous (IV) aminoglycosides, up to 44% had SNHL. Eight studies recommended hearing screening in CF children on aminoglycosides; of these, two studies recommended screening even without aminoglycoside exposure, and four studies made no recommendations. HFPTA was the most commonly recommended

2015 The Laryngoscope

53. Neonatal hearing screening: What we have achieved and what needs to be improved. (PubMed)

Journal of Pediatric Otorhinolaryngology revealed that late-onset deafness, auditory neuropathy, and the alarming percentage of newborns who fail the initial testing and then are lost to follow-up are major weaknesses of neonatal hearing screening programs. It seems that parents may be satisfied of hearing screening but in a significant percentage of them do not bring their children for follow-up or further testing due to phycho-social or other reasons. In addition, the same collection revealed (...) articles published in the International Journal of Pediatric Otorhinolaryngology show that there are still serious weakness in the neonatal hearing screening that need improvements in order to achieve an efficient and cost-effective system of deafness identification.Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

2015 International Journal of Pediatric Otorhinolaryngology

54. Response to the Letter to the Editor regarding "Otoacoustic emissions in newborn hearing screening: a systematic review of the effects of different protocols on test outcomes". (PubMed)

Response to the Letter to the Editor regarding "Otoacoustic emissions in newborn hearing screening: a systematic review of the effects of different protocols on test outcomes". 25193585 2015 05 21 2018 12 02 1872-8464 78 11 2014 Nov International journal of pediatric otorhinolaryngology Int. J. Pediatr. Otorhinolaryngol. Response to the Letter to the Editor regarding "Otoacoustic emissions in newborn hearing screening: a systematic review of the effects of different protocols on test outcomes (...) , Montréal, QC, Canada. Daniel Sam J SJ McGill Auditory Sciences Laboratory, McGill University, Montréal, QC, Canada; Department of Otolaryngology - Head and Neck Surgery, McGill University, Montréal, QC, Canada. Electronic address: sam.daniel@mcgill.ca. eng Letter Comment 2014 07 26 Ireland Int J Pediatr Otorhinolaryngol 8003603 0165-5876 IM Acta Otolaryngol. 2011 Jul;131(7):728-39 21466262 Int J Pediatr Otorhinolaryngol. 2014 May;78(5):711-7 24613088 Int J Pediatr Otorhinolaryngol. 2014 Nov;78(11):2022

2014 International journal of pediatric otorhinolaryngology

55. Newborn Hearing Screening

%. [ ] According to a study involving patients at a pediatric teaching hospital in Canada, universal newborn hearing screening lowered the median age at which mild bilateral or unilateral hearing loss was detected from 5 years to 0.8 years. [ ] Previous Next: Methods of Screening Auditory brainstem response (ABR), otoacoustic emissions (OAEs), and automated ABR (AABR) testing have all been used in newborn hearing-screening programs. For 20 years, manual or diagnostic ABR testing has been a reliable means (...) . 1978 Nov. 64(5):1386-91. . Jedrzejczak WW, Konopka W, Kochanek K, Skarzynski H. Otoacoustic emissions in newborns evoked by 0.5kHz tone bursts. Int J Pediatr Otorhinolaryngol . 2015 Sep. 79 (9):1522-6. . Johnson LC, Toro M, Vishnja E, et al. Age and Other Factors Affecting the Outcome of AABR Screening in Neonates. Hosp Pediatr . 2018 Mar. 8 (3):141-7. . Sininger YS, Starr A. Auditory Neuropathy. A New Perspective on Hearing Disorders . Singular Thomson Learning: San Diego, Calif; 2001. Hall JW 3rd

2014 eMedicine Surgery

56. Impairments of the Medial Olivocochlear System Increase the Risk of Noise-Induced Auditory Neuropathy in Laboratory Mice. (PubMed)

Impairments of the Medial Olivocochlear System Increase the Risk of Noise-Induced Auditory Neuropathy in Laboratory Mice. Impairments of the medial olivocochlear system (MOCS) increase the risk of environmentally induced auditory neuropathy spectrum disorder (ANSD).ANSD is a problem in the neural transmission of auditory information that accounts for 10% to 15% of the cases of pediatric hearing loss. The underlying mechanisms of the disorder remain poorly understood, but noise exposure (...) . MOCS protection was assessed by comparing the incidence of noise-induced ANSD among knockout mice lacking feedback and wild-type (WT) controls. The mice were screened for ANSD with distortion product otoacoustic emissions, auditory brainstem responses, and behavioral measures of gap detection. Single-unit recording procedures were used to link these deficits to impaired synaptic transmission in the ventral cochlear nucleus.ANSD manifested in noise-reared mice as intact distortion product

Full Text available with Trip Pro

2011 Otology and Neurotology

57. An evaluation of developmental examination as a method of detecting neurological, visual, and auditory handicaps in infancy. (PubMed)

Hearing Tests Humans Infant Mass Screening Nervous System Diseases diagnosis Neurologic Examination Vision Disorders diagnosis Vision Tests 1972 5 1 1972 5 1 0 1 1972 5 1 0 0 ppublish 5047162 PMC478705 J Pediatr. 1967 Aug;71(2):181-91 6029467 Can Med Assoc J. 1967 Nov 11;97(20):1199-207 6058163 Public Health. 1968 May;82(4):173-80 5657316 Child Dev. 1962 Mar;33:181-98 14457279 J Med Genet. 1964 Dec;1(2):118-51 14234108 Br Med J. 1960 Aug 6;2(5196):453-6 14445872 (...) An evaluation of developmental examination as a method of detecting neurological, visual, and auditory handicaps in infancy. 5047162 1972 09 21 2018 11 13 0007-1242 26 2 1972 May British journal of preventive & social medicine Br J Prev Soc Med An evaluation of developmental examination as a method of detecting neurological, visual, and auditory handicaps in infancy. 94-100 Roberts C J CJ Khosla T T eng Journal Article England Br J Prev Soc Med 0372672 0007-1242 IM Hearing Disorders diagnosis

Full Text available with Trip Pro

1972 British journal of preventive & social medicine

58. Pediatric applications of wideband acoustic immittance measures. (PubMed)

Pediatric applications of wideband acoustic immittance measures. Wideband acoustic immittance (WAI) measures have potential capability to improve newborn hearing screening outcomes and middle ear diagnosis for infants and children. To fully capitalize on these immittance measures for pediatric hearing care, developmental and pathologic effects need to be fully understood. Published literature on wideband immittance (reflectance, absorbance, tympanometry, and acoustic reflexes) is reviewed (...) in this article to determine pathologic effects in newborns, infants, and children relative to standard audiologic tests such as otoacoustic emissions (OAEs), standard tympanometry, air and bone conduction auditory brainstem response, and otoscopy. Infants and children with surgically confirmed otitis media with effusion have lower absorbance in the mid-frequency range (1 to 3 kHz) for the affected ear(s). Newborns that do not pass OAE screening at birth also have lower absorbance for frequencies from 1 to 3

Full Text available with Trip Pro

2013 Ear and hearing

59. Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01822184 Recruitment Status : Completed First Posted : April 2, 2013 Last Update

2013 Clinical Trials

60. High homogeneity in auditory outcome of pediatric CI-patients with mutations in Gap-Junction-Protein Beta2. (PubMed)

High homogeneity in auditory outcome of pediatric CI-patients with mutations in Gap-Junction-Protein Beta2. A controversy exists in the literature regarding better auditory performance of cochlear implanted children with mutations in the Gap-Junction-Protein Beta2 (GJB2) gene. This is partially due to insufficient numbers, lack of proper statistics, etc. As this represents a very important issue for the counselling clinician, the aim of the study was to analyze auditive outcome in GJB2-related (...) hearing loss in relation to other causes and review the literature.Retrospective study. 44 children with unilateral cochlea implants were assigned into 3 groups according to their cause of deafness: group A contained 13 patients with GJB2-related deafness, group B 15 with hereditary hearing loss and negative GJB2-screening, and group C 16 with a nonhereditary cause. The auditory outcome performance was evaluated by pure-tone audiograms (PTA), the Monosyllabic-Trochee-Polysyllabic-Word Test (MTP

2010 International Journal of Pediatric Otorhinolaryngology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>